Clinical and laboratory predictors of clomiphene response.
A prospective study was carried out on 158 anovulatory women for the purpose of finding parameters that might predict the clomiphene dose at which ovulation would occur. Both body weight and obesity were positively correlated with the dose required to achieve ovulation (P less than 0.05). Once ovulation occurred, obesity did not affect the ability to conceive. Fifty-eight women who ovulated with various doses of clomiphene, including six women who failed to ovulate, had hormonal measurements performed prior to treatment. Compared with normally ovulating controls, serum luteinizing hormone (LH), the ratio of LH to follicle-stimulating hormone (FSH), serum androgens, unbound testosterone, and unbound estradiol were elevated and sex hormone binding globulin-binding capacity (SHBG-BC) significantly lower in women receiving clomiphene. Although the ovulatory dose of clomiphene was positively correlated with both weight and obesity, neither weight nor any laboratory parameter could accurately predict the clomiphene response.
D000728:Androgens / Q000097:blood; D000858:Anovulation / Q000188:drug therapy*; D002996:Clomiphene / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003404:Creatinine / Q000097:blood; D005260:Female; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D009765:Obesity / Q000378:metabolism; D010062:Ovulation Induction / Q000379:methods; D011446:Prospective Studies; D012738:Sex Hormone-Binding Globulin / Q000032:analysis
D000728:Androgens; D006065:Gonadotropins, Pituitary; D012738:Sex Hormone-Binding Globulin; D002996:Clomiphene; D003404:Creatinine